• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Payward and GTN Join Forces to Launch xStocks Globally

chest

Payward partners with GTN to expand xStocks globally, starting with Hong Kong-listed equities.

user avatarAndrew Smith

Odds of Crypto CLARITY Act Passing Drop Significantly

chest

Predictions for the passage of the Crypto CLARITY Act have dropped to 39% following the release of a new draft bill by Senate Republicans, reflecting uncertainty about the changes made.

user avatarJacob Williams

Grayscale Submits Form 8K for Solana Staking ETF with Cash Payouts

chest

Grayscale has filed a new Form 8K with the SEC for its Solana Staking ETF, allowing quarterly cash payouts of staking rewards to shareholders.

user avatarZainab Kamara

Arbitrum Foundation Proposes $43 Million Budget for 2027

chest

The Arbitrum Foundation has proposed a significant budget of $43 million for 2027 to support operational and growth initiatives, raising discussions on DAO funding strategies and questions about spending transparency.

user avatarSon Min-ho

Ethereum Foundation Integrates AI for Enhanced Protocol Security

chest

The Ethereum Foundation's Protocol Security team is utilizing AI agents to improve the scanning of protocol repositories and devnets for vulnerabilities.

user avatarAyman Ben Youssef

Ethereum ETFs Experience Positive Inflows Amid Institutional Interest

chest

Ethereum ETFs have recorded a third consecutive day of net inflows, indicating improving institutional demand.

user avatarTando Nkube

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.